Cipla secures USFDA approval for generic Advair Diskus in all three strengths

Shares of Cipla Ltd ended at ₹1,416.00, down by ₹5.10, or 0.36%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *